AGALSIDASE BETA
Drug Details
- Generic Name
- AGALSIDASE BETA
- Brand Names
- Fabrazyme
- Application Number
- BLA103979
- Sponsor
- Genzyme Corporation
- NDC Codes
- 3
- Dosage Forms
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- AGALSIDASE BETA
Indications and Usage
1 INDICATIONS AND USAGE FABRAZYME ® is indicated for the treatment of adult and pediatric patients 2 years of age and older with confirmed Fabry disease. FABRAZYME is a hydrolytic lysosomal neutral glycosphingolipid-specific enzyme indicated for the treatment of adult and pediatric patients 2 years of age and older with confirmed Fabry disease. ( 1 )